PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeuticsSajid Khan, Daohong Zhou, Yonghan He et al.|Oncogene|2020Cited by 241
Pivotal Role for Acidic Sphingomyelinase in Cerebral Ischemia-Induced Ceramide and Cytokine Production, and Neuronal ApoptosisZai Fang Yu, Mark P. Mattson, Mariana Nikolova‐Karakashian et al.|Journal of Molecular Neuroscience|2000Cited by 209
Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic DevelopmentHu Li, Yonghan He, Huiqin Li et al.|Frontiers in Cell and Developmental Biology|2022Cited by 147
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity,Dongwen Lv, Daohong Zhou|Nature Communications|2021Cited by 145
DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomasYonghan He, Daohong Zhou|Journal of Hematology & Oncology|2020Cited by 129